AKT3 and cancer: A comprehensive investigation of the roles of the miRNA/AKT3 axis in cancer-associated pathways and their clinical relevance in different cancers will ideally enable combinatorial therapeutic strategies comprising miRNA overexpression and the administration of specific inhibitors or AKT3 specific inhibitors.